Immunopathological and microbial signatures of inflammatory bowel disease in partial RAG deficiency.
Clicks: 42
ID: 281760
2025
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
12.3
/100
42 views
15 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #15 of 15 articles by views in The Journal of experimental medicine
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Partial RAG deficiency (pRD) can manifest with systemic and tissue-specific immune dysregulation, with inflammatory bowel disease (IBD) in 15% of the patients. We aimed at identifying the immunopathological and microbial signatures associated with IBD in patients with pRD and in a mouse model of pRD (Rag1w/w) with spontaneous development of colitis. pRD patients with IBD and Rag1w/w mice showed a systemic and colonic Th1/Th17 inflammatory signature. Restriction of fecal microbial diversity, abundance of pathogenic bacteria, and depletion of microbial species producing short-chain fatty acid were observed, which were associated with impaired induction of lamina propria peripheral Treg cells in Rag1w/w mice. The use of vedolizumab in Rag1w/w mice and of ustekinumab in a pRD patient were ineffective. Antibiotics ameliorated gut inflammation in Rag1w/w mice, but only bone marrow transplantation (BMT) rescued the immunopathological and microbial signatures. Our findings shed new light in the pathophysiology of gut inflammation in pRD and establish a curative role for BMT to resolve the disease phenotype.
| Reference Key |
castagnoli2025immunopathological
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Castagnoli, Riccardo; Pala, Francesca; Subramanian, Poorani; Oguz, Cihan; Schwarz, Benjamin; Lim, Ai Ing; Burns, Andrew S; Fontana, Elena; Bosticardo, Marita; Corsino, Cristina; Angelova, Angelina; Delmonte, Ottavia M; Kenney, Heather; Riley, Deanna; Smith, Grace; Ott de Bruin, Lisa; Oikonomou, Vasileios; Dos Santos Dias, Lucas; Fink, Danielle; Bohrnsen, Eric; Kimzey, Cole D; Marseglia, Gian Luigi; Alva-Lozada, Guisela; Bergerson, Jenna R E; Brett, Ana; Brigatti, Karlla W; Dimitrova, Dimana; Dutmer, Cullen M; Freeman, Alexandra F; Ale, Hanadys; Holland, Steven M; Licciardi, Francesco; Pasic, Srdjan; Poskitt, Laura E; Potts, David E; Dasso, Joseph F; Sharapova, Svetlana O; Strauss, Kevin A; Ward, Brant R; Yilmaz, Melis; Kuhns, Douglas B; Lionakis, Michail S; Daley, Stephen R; Kong, Heidi H; Segre, Julia A; Villa, Anna; Pittaluga, Stefania; Walter, Jolan E; Vujkovic-Cvijin, Ivan; Belkaid, Yasmine; Notarangelo, Luigi D |
| Journal | The Journal of experimental medicine |
| Year | 2025 |
| DOI |
10.1084/jem.20241993
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.